Class and subclass selection in parasite-specific antibody responses
- PMID: 12855380
- DOI: 10.1016/s1471-4922(03)00139-9
Class and subclass selection in parasite-specific antibody responses
Abstract
Antibodies are characteristically induced in many parasitic infection processes. The class and subclass of the antibody response is instrumental because each isotype has a distinct biological function. It is thus crucially important for an infected individual to mount the most appropriate secondary antibody response--that is the response that has the best chance of clearing the infection and/or controlling disease. This represents a fundamental of vaccine strategies. Immuno-epidemiological surveys and in vitro models of antibody production have helped to understand some of the goals which should be achieved when designing antiparasitic vaccines.
Similar articles
-
Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections.Vaccine. 2001 Oct 12;20(1-2):59-66. doi: 10.1016/s0264-410x(01)00322-x. Vaccine. 2001. PMID: 11567746
-
Systemic and local antibody response in mice induced by a recombinant peptide fragment from Giardia lamblia variant surface protein (VSP) H7 produced by a Salmonella typhimurium vaccine strain.Int J Parasitol. 1997 Aug;27(8):965-71. doi: 10.1016/s0020-7519(97)00064-7. Int J Parasitol. 1997. PMID: 9292314
-
A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.Vaccine. 2004 Mar 12;22(9-10):1162-71. doi: 10.1016/j.vaccine.2003.09.030. Vaccine. 2004. PMID: 15003644
-
What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?Braz J Med Biol Res. 2005 Jul;38(7):979-84. doi: 10.1590/s0100-879x2005000700001. Epub 2005 Jul 4. Braz J Med Biol Res. 2005. PMID: 16007269 Review.
-
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes.Lancet Infect Dis. 2010 Oct;10(10):712-22. doi: 10.1016/S1473-3099(10)70166-3. Lancet Infect Dis. 2010. PMID: 20883967 Free PMC article. Review.
Cited by
-
Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic.J Infect Dis. 2011 Nov;204(9):1437-49. doi: 10.1093/infdis/jir545. Epub 2011 Sep 15. J Infect Dis. 2011. PMID: 21921206 Free PMC article.
-
Evaluation and characterization of Fasciola hepatica tegument protein extract for serodiagnosis of human fascioliasis.Clin Vaccine Immunol. 2012 Nov;19(11):1870-8. doi: 10.1128/CVI.00487-12. Epub 2012 Sep 26. Clin Vaccine Immunol. 2012. PMID: 23015645 Free PMC article.
-
New paradigms for functional HIV-specific nonneutralizing antibodies.Curr Opin HIV AIDS. 2013 Sep;8(5):393-401. doi: 10.1097/COH.0b013e328363d486. Curr Opin HIV AIDS. 2013. PMID: 23924999 Free PMC article. Review.
-
Schistosoma mansoni PCR+ -infected individuals in the Sudan present elevated systemic levels of chemokines when compared to uninfected and egg+ cohorts.Clin Exp Immunol. 2019 Jun;196(3):364-373. doi: 10.1111/cei.13270. Epub 2019 Mar 19. Clin Exp Immunol. 2019. PMID: 30724349 Free PMC article.
-
Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.Vaccine. 2014 Mar 5;32(11):1296-303. doi: 10.1016/j.vaccine.2013.12.057. Epub 2014 Jan 4. Vaccine. 2014. PMID: 24397898 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources